LPH |
LADPRAO GENERAL HOSPITAL PUBLIC COMPANY LIMITED |
Services/Health Care Services |
sSET |
CG Report:    |
|
|
|
|
Price (B.) |
52 Week High/Low |
P/E (X) |
P/BV (X) |
Paid-up (MB.) |
Market Cap (MB.) |
EV (MB.) |
EBITDA (MB.) |
EV/EBITDA |
4.72 |
5.10 / 2.80 |
23.78 |
2.35 |
375.00 |
3,540.00 |
4,163.41 | 307.39 |
13.54 |
|
News |
Date/Time |
Subject |
01 Mar 2021 13:07 | Schedule for the date and agenda of the Annual General Meeting of the Shareholders No. 32/2021, and the dividend payment (Amendment 1 ) |
23 Feb 2021 18:39 | Management Discussion and Analysis Yearly Ending 31 Dec 2020 |
23 Feb 2021 18:38 | Financial Statement Yearly 2020 (Audited) |
23 Feb 2021 18:38 | Financial Performance Yearly (F45) (Audited) |
23 Feb 2021 18:37 | Schedule for the date and agenda of the Annual General Meeting of the Shareholders No. 32/2021, and the dividend payment |
more
|
Company Profile |
Address |
2699 Ladprao Rd., Khlong Chaokhun Sing, Wang Thong Lang Bangkok 10310 |
Telephone |
0-2530-2244, 0-2530-2388, 0-2530-2556-69 |
Fax |
0-2539-8490 |
URL |
http://www.ladpraohospital.com |
|
Annual Report 2019 |
Establish Date |
1990 |
Listed Date |
28/10/2015 |
IPO Price (Baht) |
5.00 |
@Par0.50 Baht |
IPO Financial Advisory |
KGI SECURITIES (THAILAND) PUBLIC COMPANY LIMITED
|
Par |
0.50 Baht |
Last Par Change |
N/A |
Business |
The business is divided into 3 business operations (1) Medical Services Business (hospital) operated through Ladprao Hospital, the 24-hours service private hospital. (2) Laboratory and Researching Business operated by Asia Medical and Agricultural Laboratory and Research Center Company Limited (3) Medical and Business Support operated by Asia Business Management Center Company Limited. Its main business scopes are including conduct hospital's medical statistics by statistical specialist for scoring the social security patients, provide legal services , and perform business development function of the group for the Company and its subsidiaries. |
Free Float |
11 Mar 2020 |
12 Mar 2019 |
% /Shareholders |
51.32% |
5,067 |
55.00% |
5,707 |
|
Foreign Shareholders |
0.04% (As of 05/03/2021) |
Foreign Limit |
49.00% |
NVDR Shareholders |
1.26% (As of 05/03/2021) |
|
|
5 Yr Price Performance (Adjusted Price) |
|
Price Performance (Adjusted Price) |
Compare to Stock (%) |
Compare to Sector (%) |
Compare to Market (%) |
5 Days |
0.85 |
-3.62 |
-2.24 |
20 Days |
4.42 |
1.80 |
1.21 |
60 Days |
0.85 |
-0.13 |
-5.30 |
120 Days |
8.76 |
1.39 |
-7.60 |
YTD |
3.06 |
-1.89 |
-3.27 |
P/E (X) |
23.78 |
48.84 |
40.32 |
P/BV (X) |
2.35 |
3.78 |
1.75 |
Turnover Ratio (%) |
0.07 |
0.29 |
1.71 |
|
Top 10 Major Shareholders(@28 Aug 2020) |
Share |
% |
1. |
บริษัท LP HOLDING COMPANY LIMITED |
250,274,100 |
33.37 |
2. |
นาย พิพัฒน์ เศวตวิลาศ |
37,543,684 |
5.01 |
3. |
บริษัท NCH 2555 HOLDING COMPANY LIMITED |
34,749,880 |
4.63 |
4. |
บริษัท LADPRAO GENERAL HOSPITAL PUBLIC COMPANY LIMITED |
30,000,000 |
4.00 |
5. |
นาย อังกูร ฉันทนาวานิช |
23,636,600 |
3.15 |
6. |
นาง วิมลทิพย์ พงศธร |
22,900,000 |
3.05 |
7. |
ธนาคาร PCL. |
16,800,000 |
2.24 |
8. |
บริษัท Thai NVDR Company Limited |
9,650,268 |
1.29 |
9. |
นาย สมศักดิ์ โล่ห์เลขา |
7,765,360 |
1.04 |
10. |
นาย สามารถ ยิ้มศิริ |
7,056,000 |
0.94 |
Management |
Position |
1. |
Mr. SOMSAK LOLEKHA |
CHAIRMAN OF THE BOARD |
2. |
Mr. PIPAT SAVETVILAS |
DEPUTY CHAIRMAN |
3. |
Mr. UNGOON CHANTANAVANICH |
CHIEF EXECUTIVE OFFICER / DIRECTOR |
4. |
Mr. SOMCHAO TANTERDTHAM |
DIRECTOR |
5. |
Mrs. WICHUDA UMPORNPHOL |
DIRECTOR |
6. |
Mrs. SUPAPORN KANTHAMANOND |
DIRECTOR |
7. |
Mr. VIRAT VONGSAENGNAK |
DIRECTOR |
8. |
Mr. PIBOON LIMPRAPAT |
INDEPENDENT DIRECTOR / CHAIRMAN OF AUDIT COMMITTEE |
9. |
Mrs. BENJAWAN THANAPAISALPIPATH |
INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
10. |
Mr. KULTHON NAKAPROM |
INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
11. |
Miss THIPAWAN UTHAISANG |
INDEPENDENT DIRECTOR / AUDIT COMMITTEE |
|
Statistics |
YTD 05 Mar 2021 |
2020 30 Dec 2020 |
2019 30 Dec 2019 |
Listed share (M.) |
750.00 |
750.00 |
750.00 |
Market Cap (MB.) |
3,540.00 |
3,435.00 |
3,615.00 |
Price (B./share) |
4.72 |
4.58 |
4.82 |
BVPS (B./Share) |
2.01 |
1.93 |
1.95 |
P/BV (X) |
2.35 |
2.37 |
2.48 |
P/E (X) |
23.78 |
27.37 |
36.29 |
Turnover Ratio (%) |
1.61 |
9.01 |
11.14 |
Value Trade/Day (MB.) |
1.28 |
1.19 |
1.82 |
Beta |
0.65 |
0.67 |
0.39 |
|
Rate of Return |
YTD |
2020 |
2019 |
Price Change (%) |
3.06 |
-4.98 |
-14.69 |
Dividend Yield (%) |
3.18 |
2.73 |
4.15 |
Payout Ratio |
0.50 |
0.60 |
1.32 |
Dividend Policy |
Not less than 50% of net profit after tax and allocation to reserves as required by law(with additional conditions) |
Dividend |
Operation Period |
Dividend/Share |
Unit |
Payment Date |
Type |
01 Jan 2020 - 30 Jun 2020 |
0.05 |
Baht |
09 Sep 2020 |
Cash |
01 Jan 2019 - 31 Dec 2019 |
0.05 |
Baht |
22 May 2020 |
Cash |
01 Jan 2019 - 30 Sep 2019 |
0.075 |
Baht |
12 Dec 2019 |
Cash |
01 Jan 2018 - 31 Dec 2018 |
0.10 |
Baht |
17 May 2019 |
Cash |
01 Jan 2018 - 30 Sep 2018 |
0.10 |
Baht |
12 Dec 2018 |
Cash |
01 Jan 2017 - 31 Dec 2017 |
0.10 |
Baht |
18 May 2018 |
Cash |
|
|
Auditor (Effective Until 31/12/2021) |
MR. PERADATE PONGSATHIANSAK/DHARMNITI AUDITING CO., LTD. |
MISS NANNAPHAT WANNASOMBOON/DHARMNITI AUDITING CO., LTD. |
MISS SORAYA TINTASUWAN/DHARMNITI AUDITING CO., LTD. |
|
F/S Year ended |
31/12 |
Latest Type of Report |
Unqualified opinion |
|
|
Statement of Financial Position (MB.) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
2018 (01/01/18 -31/12/18) |
2017 (01/01/17 -31/12/17) |
Cash |
159.68 |
67.90 |
59.38 |
208.64 |
A/R Net |
194.74 |
157.76 |
99.08 |
104.47 |
Inventories |
29.77 |
24.57 |
23.50 |
21.64 |
Current Assets |
518.59 |
362.38 |
371.28 |
707.48 |
PP&E Net |
1,450.83 |
1,400.96 |
1,293.79 |
1,204.58 |
Total Assets |
2,226.83 |
1,922.02 |
1,817.09 |
2,090.01 |
OD |
17.61 |
15.10 |
5.62 |
27.32 |
A/P Net |
230.52 |
179.71 |
174.42 |
208.85 |
Current portion of LT |
103.48 |
80.73 |
60.15 |
55.54 |
Current Liabilities |
380.30 |
298.67 |
254.21 |
316.19 |
Non-Current Liabilities |
401.14 |
249.67 |
168.09 |
192.68 |
Total Liabilities |
781.43 |
548.34 |
422.29 |
508.87 |
Authorized Capital |
375.00 |
375.00 |
375.00 |
375.00 |
Paid-Up Capital |
375.00 |
375.00 |
375.00 |
375.00 |
Premium (Discount) on Share Capital |
922.83 |
922.83 |
922.83 |
922.83 |
Other Surplus (Deficit) |
5.63 |
5.63 |
5.63 |
5.63 |
Retained Earnings (Deficit) |
337.52 |
264.56 |
287.51 |
276.60 |
Treasury Stock |
197.24 |
197.24 |
197.24 |
- |
Shareholders' Equity |
1,443.74 |
1,370.78 |
1,393.73 |
1,580.07 |
Minority Interest |
1.66 |
2.90 |
1.06 |
1.07 |
more |
|
Statement of Comprehensive Income (MB.) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
2018 (01/01/18 -31/12/18) |
2017 (01/01/17 -31/12/17) |
Sales |
1,801.26 |
1,581.44 |
1,525.49 |
1,427.83 |
Other Income |
13.36 |
15.39 |
72.73 |
96.82 |
Total Revenues |
1,814.63 |
1,596.83 |
1,598.22 |
1,524.65 |
COGs |
1,359.97 |
1,224.26 |
1,156.83 |
1,067.47 |
SG&A |
235.46 |
193.57 |
188.46 |
176.27 |
Total Expenses |
1,642.56 |
1,464.63 |
1,405.52 |
1,292.24 |
EBITDA |
307.39 |
235.71 |
290.92 |
307.50 |
Depre. & Amor. |
135.32 |
103.52 |
98.22 |
75.10 |
EBIT |
172.06 |
132.19 |
192.70 |
232.41 |
Net Profit |
142.89 |
110.49 |
156.95 |
193.83 |
EPS (B.) |
0.20 |
0.15 |
0.21 |
0.26 |
more |
|
Statement of Cash Flow (MB.) |
2020 (01/01/20 -31/12/20) |
2019 (01/01/19 -31/12/19) |
2018 (01/01/18 -31/12/18) |
2017 (01/01/17 -31/12/17) |
Operating Cash Flow |
289.92 |
210.61 |
161.54 |
251.48 |
Investing Cash Flow |
-146.43 |
-116.72 |
126.50 |
-3.20 |
Financing Cash Flow |
-51.71 |
-85.37 |
-437.30 |
-159.70 |
Net Cash Flow |
91.78 |
8.52 |
-149.26 |
88.58 |
more |
|
Ratios |
2020 |
2019 |
2018 |
Current Ratio (X) |
1.36 |
1.21 |
1.46 |
ROE (%) |
10.15 |
7.99 |
10.56 |
ROA (%) |
8.29 |
7.07 |
9.86 |
D/E (X) |
0.54 |
0.40 |
0.30 |
Total Asset Turnover (X) |
0.87 |
0.85 |
0.82 |
Gross Profit Margin (%) |
24.50 |
22.59 |
24.17 |
EBIT Margin (%) |
9.48 |
8.28 |
12.06 |
Net Profit Margin (%) |
7.87 |
6.92 |
9.82 |
Capital Movement (Last 3 Year) |
Date |
CA Type |
Changed paid up share |
Paid up share |
Par |
No Information Found |
|
Growth Rate (%) |
2020 |
2019 |
2018 |
Sales Growth |
13.90 |
3.67 |
6.84 |
COGs Growth |
11.08 |
5.83 |
8.37 |
Total Revenue Growth |
13.64 |
-0.09 |
4.83 |
Total Expense Growth |
12.15 |
4.21 |
8.77 |
Net Profit Growth |
29.32 |
-29.60 |
-19.03 |
Cash Cycle |
2020 |
2019 |
2018 |
A/R Turnover (Times) |
10.22 |
12.31 |
14.99 |
Avg. Collection Period (Days) |
35.71 |
29.64 |
24.35 |
Inventory Turnover (Times) |
50.06 |
50.94 |
51.26 |
Avg. Inventory Period (Days) |
7.29 |
7.17 |
7.12 |
A/P Turnover (Times) |
6.63 |
6.91 |
6.04 |
Avg. Payment Period (Days) |
55.05 |
52.79 |
60.46 |
Cash Cycle (Days) |
-12.04 |
-15.98 |
-28.99 |
|
Trading Sign (Latest) |
Trading Alert |
Posted Date |
Lifted Date |
No Information Found |
Market Alert (Latest) |
No Information Found |
more
|
|
Other Securities |
Securities Name |
- |
|
|
 |
Source: www.set.or.th (Copyright © The Stock Exchange of Thailand) |
|